Company Filing History:
Years Active: 2012-2019
Title: Eoin Coakley: Innovator in HIV Research
Introduction
Eoin Coakley is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of HIV research, particularly in the development of methods for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors. With a total of 2 patents, his work is crucial in advancing treatment options for HIV patients.
Latest Patents
Eoin Coakley's latest patents focus on innovative methods for assessing the susceptibility of HIV-1 viruses to non-nucleoside reverse transcriptase inhibitors (NNRTIs). The first patent describes methods that involve detecting mutations in the gene encoding reverse transcriptase of HIV-1, specifically at codons 65, 69, or 74. These mutations can occur alone or in combination with others, providing a comprehensive approach to understanding viral behavior. The second patent reiterates these methods and compositions, emphasizing the importance of identifying combinations of mutations associated with hypersusceptibility to NNRTIs.
Career Highlights
Eoin Coakley is currently associated with Monogram Biosciences, Inc., where he continues to work on groundbreaking research in the field of HIV. His expertise and innovative approaches have positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Eoin collaborates with Neil T Parkin, contributing to the advancement of research and innovation in their field. Their partnership exemplifies the importance of teamwork in scientific discovery.
Conclusion
Eoin Coakley's contributions to HIV research through his patents and collaborations highlight his commitment to improving treatment options for patients. His work continues to pave the way for advancements in the understanding and management of HIV.